Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 452

1.

Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm.

McGirt MJ, Pradilla G, Legnani FG, Thai QA, Recinos PF, Tamargo RJ, Clatterbuck RE.

Neurosurgery. 2006 May;58(5):945-51; discussion 945-51.

PMID:
16639331
2.

Influence of simvastatin on microthrombosis in the brain after subarachnoid hemorrhage in rats: a preliminary study.

Wang Z, Chen G, Zhu WW, Bian JY, Shen XO, Zhou D.

Ann Clin Lab Sci. 2010 Winter;40(1):32-42.

PMID:
20124328
3.

Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage.

Belen D, Besalti O, Yiğitkanli K, Kösemehmetoğlu K, Simşek S, Bolay H.

Acta Neurochir (Wien). 2007 Oct;149(10):1041-7; discussion 1047-8. Epub 2007 Sep 17.

PMID:
17876498
4.
5.

Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm.

Lin CL, Dumont AS, Calisaneller T, Kwan AL, Hwong SL, Lee KS.

Surg Neurol. 2005 Sep;64(3):201-5; discussion 205-6.

PMID:
16099244
6.

Delayed administration of the K+ channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.

Kwan AL, Lin CL, Wu CS, Chen EF, Howng SL, Kassell NF, Lee KS.

Acta Neurochir (Wien). 2000;142(2):193-7.

PMID:
10795894
7.

The novel 5-lipoxygenase inhibitor ABT-761 attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage.

Barbosa MD, Arthur AS, Louis RH, MacDonald T, Polin RS, Gazak C, Kassell NF.

Neurosurgery. 2001 Nov;49(5):1205-12; discussion 1212-3.

PMID:
11846914
8.

Prevention of cerebral vasospasm by a capsaicin derivative, glyceryl nonivamide, in an experimental model of subarachnoid hemorrhage.

Lin CL, Lo YC, Chang CZ, Kwan AL, Chen IJ, Howng SL.

Surg Neurol. 2001 May;55(5):297-301.

PMID:
11516473
9.

Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits.

Pradilla G, Wang PP, Legnani FG, Ogata L, Dietsch GN, Tamargo RJ.

J Neurosurg. 2004 Jul;101(1):88-92.

PMID:
15255256
10.

Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.

Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N.

Neurosurgery. 2006 Nov;59(5):1102-7; discussion 1107-8.

PMID:
17143244
11.

Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage.

Kwan AL, Lin CL, Yen CP, Winardi W, Su YF, Winardi D, Dai ZK, Jeng AY, Kassell NF, Howng SL, Wang CJ.

Exp Biol Med (Maywood). 2006 Jun;231(6):1069-74.

PMID:
16741051
12.

Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage.

Momin EN, Schwab KE, Chaichana KL, Miller-Lotan R, Levy AP, Tamargo RJ.

Neurosurgery. 2009 Nov;65(5):937-45; discussion 945. doi: 10.1227/01.NEU.0000356974.14230.B8.

PMID:
19834407
13.

Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage.

Stoodley M, Weihl CC, Zhang ZD, Lin G, Johns LM, Kowalczuk A, Ghadge G, Roos RP, Macdonald RL.

Neurosurgery. 2000 May;46(5):1193-202; discussion 1202-3.

PMID:
10807252
14.

Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage.

Toyoda K, Faraci FM, Watanabe Y, Ueda T, Andresen JJ, Chu Y, Otake S, Heistad DD.

Circ Res. 2000 Oct 27;87(9):818-24.

15.

Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin.

Ito Y, Isotani E, Mizuno Y, Azuma H, Hirakawa K.

J Cardiovasc Pharmacol. 2000 Jan;35(1):45-50.

PMID:
10630732
16.

Potential contribution of nuclear factor-kappaB to cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.

Zhou ML, Shi JX, Hang CH, Cheng HL, Qi XP, Mao L, Chen KF, Yin HX.

J Cereb Blood Flow Metab. 2007 Sep;27(9):1583-92. Epub 2007 Feb 7.

PMID:
17293842
17.

Effects of raloxifene on cerebral vasospasm after experimental Subarachnoid Hemorrhage in rabbits.

Gürses L, Seçkin H, Simşek S, Senel OO, Yigitkanli K, Oztürk E, Beşalti O, Belen D, Bavbek M.

Surg Neurol. 2009 Nov;72(5):490-4; discussion 494-5. doi: 10.1016/j.surneu.2008.11.007. Epub 2009 Jan 14.

PMID:
19147193
18.

Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits.

Pradilla G, Thai QA, Legnani FG, Hsu W, Kretzer RM, Wang PP, Tamargo RJ.

Neurosurgery. 2004 Dec;55(6):1393-9; discussion 1399-1400.

PMID:
15574221
19.

Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.

Kwan AL, Lin CL, Yanamoto H, Howng SL, Kassell NF, Lee KS.

Neurosurgery. 1998 Feb;42(2):347-50; discussion 350-1.

PMID:
9482186
20.

Effect of raloxifene on cerebral vasospasm following experimental subarachnoid hemorrhage in rats.

Gulsen S, Inci S, Yuruk S, Yasar U, Ozgen T.

Neurol Med Chir (Tokyo). 2007 Dec;47(12):537-42; discussion 542.

Supplemental Content

Support Center